Response to the letter regarding ‘Outcomes of functional ventricular tachycardia ablation vs. medical therapy in Chagas cardiomyopathy patients with implantable cardioverter-defibrillators: a competing risks analysis’
Open Access
- 2 September 2026
- journal article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (9)
Abstract
No abstract availableFunding Information
- Conselho Nacional de DesenvolvimentoCientífico e Tecnológico (308288/2020-3)
This publication has 6 references indexed in Scilit:
- Outcomes of functional ventricular tachycardia ablation vs. medical therapy in Chagas cardiomyopathy patients with implantable cardioverter-defibrillators: a competing risks analysisEP Europace, 2025
- Assessing the role of ICD in Chagas heart disease: a systematic review, meta-analysis, and meta-regressionJournal of Interventional Cardiac Electrophysiology, 2025
- Extrastimuli-assisted functional mapping improves ventricular tachycardia ablation outcomes: A systematic review, meta-analysis, and meta-regressionHeart Rhythm, 2025
- Catheter Ablation or Antiarrhythmic Drugs for Ventricular TachycardiaNew England Journal of Medicine, 2025
- Evaluation of patients with implantable cardioverter‐defibrillator in a Latin American tertiary centerJournal of Cardiovascular Electrophysiology, 2024
- Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular TachycardiaJACC, 2022